ArticleActa pharmaceutica Sinica. B2024

Erratum: Author correction to 'Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects' [Acta Pharmaceutica Sinica B 13 (2023) 2138-2151].

Wei Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.